INE939A01011
INE939A01011
STRIDES PHARMA SCI LTD
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 46.279.660.000 | 43.916.820.000 | 5.4% |
| Cost of Revenue | 21.673.590.000 | 21.339.110.000 | 1.6% |
| Gross Profit | 24.606.070.000 | 22.577.710.000 | 9.0% |
| 18.435.920.000 | 16.781.680.000 | 9.9% | |
| Operating Income | 6.170.150.000 | 5.796.030.000 | 6.5% |
| Pretax Income | 6.686.860.000 | 4.869.210.000 | 37.3% |
| Net Income Common Stockholders | 5.561.930.000 | 35.934.550.000 | 84.5% |
| -- | -- | -- | |
| -- | -- | -- |